Together with the IP-MS, transcriptomic, and western blotting results, these findings provide compelling evidence that RAD23B promotes CRC metastasis via the Talin1/Integrin αv/β1/PI3K/AKT/MMP9 signaling axis. Here, RAD23B is linked to colorectal carcinoma.